Trillium Asset Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,066
Closed -$951K 274
2019
Q3
$951K Sell
11,066
-14
-0.1% -$1.06K 0.04% 187
2019
Q2
$718K Buy
11,080
+1,288
+13% +$80.2K 0.03% 184
2019
Q1
$612K Buy
9,792
+735
+8% +$34.6K 0.03% 198
2018
Q4
$352K Buy
9,057
+45
+0.5% +$2K 0.02% 210
2018
Q3
$514K Buy
9,012
+134
+2% +$8.38K 0.03% 200
2018
Q2
$709K Buy
8,878
+162
+2% +$13.4K 0.04% 190
2018
Q1
$755K Buy
8,716
+70
+0.8% +$5.65K 0.04% 188
2017
Q4
$597K Buy
8,646
+97
+1% +$7.76K 0.03% 188
2017
Q3
$777K Buy
8,549
+138
+2% +$11.8K 0.04% 180
2017
Q2
$626K Buy
+8,411
New +$674K 0.04% 186

Other funds holding NVRO

Trillium Asset Management's NVRO Position: Q4 2019 in Review

Trillium Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2019, closing a stake of 11,066 shares — an estimated $951K sold.

Trillium Asset Management first reported a position in NVRO in Q2 2017 and held it in 10 quarters. The position peaked at $951K in Q3 2019. 191 funds tracked by Wall St. Rank hold NVRO as of Q4 2019.

  • Trillium Asset Management reported no remaining NEVRO CORP. position as of Q4 2019 after selling out during the quarter.
  • Trillium Asset Management sold 11,066 NEVRO CORP. shares in Q4 2019, an estimated $951K.
  • Trillium Asset Management first reported a position in NEVRO CORP. in Q2 2017 and held it in 10 quarters.
  • Trillium Asset Management's NEVRO CORP. position peaked at $951K in Q3 2019.
  • 191 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2019.

Based on Trillium Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.